Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Osilodrostat Therapy and 11C-methionine PET to IMprove Corticotroph Pituitary Adenoma Detection and Localisation in Patients With Cushing's Disease

NCT06701838 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT06701838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06701838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Osilodrostat Therapy and 11C-methionine PET to IMprove Corticotroph Pituitary Adenoma Detection and Localisation in Patients With Cushing's Disease
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Not yet recruiting
Start date
December 3, 2024
Completion date
July 5, 2026
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cushing's disease, hypercortisolism, pituitary acth secreting adenoma, pituitary adenoma